KLK3 and prostate carcinoma: However, a significant fraction of prostate cancers detected solely on the basis of an increased serum PSA are subclinical indolent tumors, while only a small fraction of these tumors actually progress into an aggressive form, providing a major clinical challenge to distinguish between the two.